Medicine and Dentistry
Patient
100%
Hematopoietic Cell
66%
Transplantation
64%
Cell Transplantation
60%
Therapeutic Procedure
50%
Acute Myeloid Leukemia
32%
Blood
27%
Myelodysplastic Syndrome
26%
Combination Therapy
24%
Chronic Graft Versus Host Disease
23%
Survival
23%
Inpatient
21%
Assessment
19%
Graft Versus Host Reaction
19%
Azacitidine
17%
Adult
17%
Hematopoietic Stem Cell Transplantation
17%
Leukemia
16%
Disease
16%
Donor
14%
T Cell
14%
Bone Marrow Transplantation
13%
Oncology
13%
Toxicity
13%
Mortality
12%
Analysis
12%
Endothelial Cell
12%
Predictor
12%
Bone Marrow
12%
Overall Survival
11%
Fatigue
11%
Symptom
11%
Spontaneous Remission
10%
Clinical Trial
10%
Incidence
10%
Physician
10%
Health Care
9%
Follow up
9%
Non-Hodgkin Lymphoma
9%
Diagnosis
9%
Neoplasm
9%
Chemotherapy
9%
Acute Graft Versus Host Disease
9%
Stem Cell Transplant
9%
Treatment Response
8%
Cell Therapy
8%
Fluorine-18
8%
Treatment of Myelodysplastic Syndrome
8%
Hematopoietic Stem Cell
8%
Survivorship in Cancer Care
8%
Immunology and Microbiology
Transplantation
31%
Cell Transplantation
27%
Cells
17%
Graft-Versus-Host Disease
11%
Hematopoietic Stem Cell Transplantation
9%
Bone Marrow
9%
Myeloid
9%
T Cell
8%
Survival
8%
Ferritin
8%
Mortality
7%
Age
6%
Dose
5%
Overall Survival
5%
Development
5%
Pharmacology, Toxicology and Pharmaceutical Science
Myelodysplastic Syndrome
18%
Acute Myeloid Leukemia
17%
Azacitidine
12%
Entinostat
9%
Survival
6%
Leukemia
6%
Diseases
6%
Toxicity
5%
Chronic Myelomonocytic Leukemia
5%
Neoplasm
5%
